Literature DB >> 34191025

Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection.

Rebecca L Smith1,2,3, Laura L Gibson4, Pamela P Martinez1,5,6, Ruian Ke7, Agha Mirza8, Madison Conte8, Nicholas Gallagher9, Abigail Conte10, Leyi Wang11, Richard Fredrickson11, Darci C Edmonson1, Melinda E Baughman1, Karen K Chiu1, Hannah Choi1, Tor W Jensen1,12, Kevin R Scardina1, Shannon Bradley1, Stacy L Gloss1, Crystal Reinhart1, Jagadeesh Yedetore1, Alyssa N Owens13, John Broach14,15, Bruce Barton16,17, Peter Lazar16, Darcy Henness18, Todd Young18, Alastair Dunnett18, Matthew L Robinson8, Heba H Mostafa9, Andrew Pekosz10, Yukari C Manabe8, William J Heetderks19, David D McManus20, Christopher B Brooke1,5.   

Abstract

BACKGROUND: Serial screening is critical for restricting spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by facilitating timely identification of infected individuals to interrupt transmission. Variation in sensitivity of different diagnostic tests at different stages of infection has not been well documented.
METHODS: In a longitudinal study of 43 adults newly infected with SARS-CoV-2, all provided daily saliva and nasal swabs for quantitative reverse transcription polymerase chain reaction (RT-qPCR), Quidel SARS Sofia antigen fluorescent immunoassay (FIA), and live virus culture.
RESULTS: Both RT-qPCR and Quidel SARS Sofia antigen FIA peaked in sensitivity during the period in which live virus was detected in nasal swabs, but sensitivity of RT-qPCR tests rose more rapidly prior to this period. We also found that serial testing multiple times per week increases the sensitivity of antigen tests.
CONCLUSIONS: RT-qPCR tests are more effective than antigen tests at identifying infected individuals prior to or early during the infectious period and thus for minimizing forward transmission (given timely results reporting). All tests showed >98% sensitivity for identifying infected individuals if used at least every 3 days. Daily screening using antigen tests can achieve approximately 90% sensitivity for identifying infected individuals while they are viral culture positive.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  RT-qPCR testing; SARS-CoV-2; antigen testing; diagnostic testing; test sensitivity

Mesh:

Substances:

Year:  2021        PMID: 34191025      PMCID: PMC8448437          DOI: 10.1093/infdis/jiab337

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   7.759


  11 in total

1.  The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia.

Authors:  Stefan Flasche; Sebastian Funk; Martin Pavelka; Kevin Van-Zandvoort; Sam Abbott; Katharine Sherratt; Marek Majdan; Pavol Jarčuška; Marek Krajčí
Journal:  Science       Date:  2021-03-23       Impact factor: 47.728

2.  Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in Intercollegiate Athletics Not Fully Mitigated With Daily Antigen Testing.

Authors:  Gage K Moreno; Katarina M Braun; Ian W Pray; Hannah E Segaloff; Ailam Lim; Keith Poulsen; Jonathan Meiman; James Borcher; Ryan P Westergaard; Michael K Moll; Thomas C Friedrich; David H O'Connor
Journal:  Clin Infect Dis       Date:  2021-07-15       Impact factor: 9.079

3.  Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.

Authors:  Shutoku Matsuyama; Naganori Nao; Kazuya Shirato; Miyuki Kawase; Shinji Saito; Ikuyo Takayama; Noriyo Nagata; Tsuyoshi Sekizuka; Hiroshi Katoh; Fumihiro Kato; Masafumi Sakata; Maino Tahara; Satoshi Kutsuna; Norio Ohmagari; Makoto Kuroda; Tadaki Suzuki; Tsutomu Kageyama; Makoto Takeda
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-12       Impact factor: 11.205

Review 4.  Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure.

Authors:  Lauren M Kucirka; Stephen A Lauer; Oliver Laeyendecker; Denali Boon; Justin Lessler
Journal:  Ann Intern Med       Date:  2020-05-13       Impact factor: 25.391

5.  Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection.

Authors:  A E Jääskeläinen; M J Ahava; P Jokela; L Szirovicza; S Pohjala; O Vapalahti; M Lappalainen; J Hepojoki; S Kurkela
Journal:  J Clin Virol       Date:  2021-03-05       Impact factor: 3.168

6.  Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses - Wisconsin, September-October 2020.

Authors:  Ian W Pray; Laura Ford; Devlin Cole; Christine Lee; John Paul Bigouette; Glen R Abedi; Dena Bushman; Miranda J Delahoy; Dustin Currie; Blake Cherney; Marie Kirby; Geroncio Fajardo; Motria Caudill; Kimberly Langolf; Juliana Kahrs; Patrick Kelly; Collin Pitts; Ailam Lim; Nicole Aulik; Azaibi Tamin; Jennifer L Harcourt; Krista Queen; Jing Zhang; Brett Whitaker; Hannah Browne; Magdalena Medrzycki; Patricia Shewmaker; Jennifer Folster; Bettina Bankamp; Michael D Bowen; Natalie J Thornburg; Kimberly Goffard; Brandi Limbago; Allen Bateman; Jacqueline E Tate; Douglas Gieryn; Hannah L Kirking; Ryan Westergaard; Marie Killerby
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-01-01       Impact factor: 35.301

7.  Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.

Authors:  Jesse J Waggoner; Victoria Stittleburg; Renee Pond; Youssef Saklawi; Malaya K Sahoo; Ahmed Babiker; Laila Hussaini; Colleen S Kraft; Benjamin A Pinsky; Evan J Anderson; Nadine Rouphael
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

8.  Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States.

Authors:  A David Paltiel; Amy Zheng; Rochelle P Walensky
Journal:  JAMA Netw Open       Date:  2020-07-01

Review 9.  Inferred duration of infectious period of SARS-CoV-2: rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases.

Authors:  Andrew William Byrne; David McEvoy; Aine B Collins; Kevin Hunt; Miriam Casey; Ann Barber; Francis Butler; John Griffin; Elizabeth A Lane; Conor McAloon; Kirsty O'Brien; Patrick Wall; Kieran A Walsh; Simon J More
Journal:  BMJ Open       Date:  2020-08-05       Impact factor: 2.692

10.  Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.

Authors:  Daniel B Larremore; Bryan Wilder; Evan Lester; Soraya Shehata; James M Burke; James A Hay; Milind Tambe; Michael J Mina; Roy Parker
Journal:  Sci Adv       Date:  2021-01-01       Impact factor: 14.136

View more
  39 in total

Review 1.  Point-of-care diagnostics: recent developments in a pandemic age.

Authors:  Harshit Harpaldas; Siddarth Arumugam; Chelsey Campillo Rodriguez; Bhoomika Ajay Kumar; Vivian Shi; Samuel K Sia
Journal:  Lab Chip       Date:  2021-11-25       Impact factor: 6.799

Review 2.  Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Pawana Sharma; Sarah Berhane; Susanna S van Wyk; Nicholas Nyaaba; Julie Domen; Melissa Taylor; Jane Cunningham; Clare Davenport; Sabine Dittrich; Devy Emperador; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Jan Y Verbakel; Yemisi Takwoingi; Sian Taylor-Phillips; Ann Van den Bruel; Jonathan J Deeks
Journal:  Cochrane Database Syst Rev       Date:  2022-07-22

3.  Comparison of Rapid Antigen Tests' Performance Between Delta and Omicron Variants of SARS-CoV-2 : A Secondary Analysis From a Serial Home Self-testing Study.

Authors:  Apurv Soni; Carly Herbert; Andreas Filippaios; John Broach; Andres Colubri; Nisha Fahey; Kelsey Woods; Janvi Nanavati; Colton Wright; Taylor Orwig; Karen Gilliam; Vik Kheterpal; Thejas Suvarna; Chris Nowak; Summer Schrader; Honghuang Lin; Laurel O'Connor; Caitlin Pretz; Didem Ayturk; Elizabeth Orvek; Julie Flahive; Peter Lazar; Qiming Shi; Chad Achenbach; Robert Murphy; Matthew Robinson; Laura Gibson; Pamela Stamegna; Nathaniel Hafer; Katherine Luzuriaga; Bruce Barton; William Heetderks; Yukari C Manabe; David McManus
Journal:  Ann Intern Med       Date:  2022-10-11       Impact factor: 51.598

4.  Comparison of Home Antigen Testing With RT-PCR and Viral Culture During the Course of SARS-CoV-2 Infection.

Authors:  Victoria T Chu; Noah G Schwartz; Marisa A P Donnelly; Meagan R Chuey; Raymond Soto; Anna R Yousaf; Emily N Schmitt-Matzen; Sadia Sleweon; Jasmine Ruffin; Natalie Thornburg; Jennifer L Harcourt; Azaibi Tamin; Gimin Kim; Jennifer M Folster; Laura J Hughes; Suxiang Tong; Ginger Stringer; Bernadette A Albanese; Sarah E Totten; Meghan M Hudziec; Shannon R Matzinger; Elizabeth A Dietrich; Sarah W Sheldon; Sarah Stous; Eric C McDonald; Brett Austin; Mark E Beatty; J Erin Staples; Marie E Killerby; Christopher H Hsu; Jacqueline E Tate; Hannah L Kirking; Almea Matanock
Journal:  JAMA Intern Med       Date:  2022-07-01       Impact factor: 44.409

5.  Comparative analyses of eighteen rapid antigen tests and RT-PCR for COVID-19 quarantine and surveillance-based isolation.

Authors:  Chad R Wells; Abhishek Pandey; Seyed M Moghadas; Burton H Singer; Gary Krieger; Richard J L Heron; David E Turner; Justin P Abshire; Kimberly M Phillips; A Michael Donoghue; Alison P Galvani; Jeffrey P Townsend
Journal:  Commun Med (Lond)       Date:  2022-07-09

Review 6.  Performance of Antigen Detection Tests for SARS-CoV-2: A Systematic Review and Meta-Analysis.

Authors:  Anastasia Tapari; Georgia G Braliou; Maria Papaefthimiou; Helen Mavriki; Panagiota I Kontou; Georgios K Nikolopoulos; Pantelis G Bagos
Journal:  Diagnostics (Basel)       Date:  2022-06-04

7.  Evaluation of Four Point of Care (POC) Antigen Assays for the Detection of the SARS-CoV-2 Variant Omicron.

Authors:  Justin Hardick; Nicholas Gallagher; Andrew Pekosz; Yukari C Manabe; Heba H Mostafa; Jaiprasath Sachithanandham; Amary Fall; Zishan Siddiqui
Journal:  Microbiol Spectr       Date:  2022-05-26

8.  Limitations of Molecular and Antigen Test Performance for SARS-CoV-2 in Symptomatic and Asymptomatic COVID-19 Contacts.

Authors:  Matthew L Robinson; Agha Mirza; Nicholas Gallagher; Alec Boudreau; Lydia Garcia Jacinto; Tong Yu; Julie Norton; Chun Huai Luo; Abigail Conte; Ruifeng Zhou; Kim Kafka; Justin Hardick; David D McManus; Laura L Gibson; Andrew Pekosz; Heba H Mostafa; Yukari C Manabe
Journal:  J Clin Microbiol       Date:  2022-06-22       Impact factor: 11.677

9.  Clinical evaluation of the Diagnostic Analyzer for Selective Hybridization (DASH): A point-of-care PCR test for rapid detection of SARS-CoV-2 infection.

Authors:  Chad J Achenbach; Matthew Caputo; Claudia Hawkins; Lauren C Balmert; Chao Qi; Joseph Odorisio; Etienne Dembele; Alema Jackson; Hiba Abbas; Jennifer K Frediani; Joshua M Levy; Paulina A Rebolledo; Russell R Kempker; Annette M Esper; Wilbur A Lam; Greg S Martin; Robert L Murphy
Journal:  PLoS One       Date:  2022-06-16       Impact factor: 3.752

10.  Semi-nested RT-PCR enables sensitive and high-throughput detection of SARS-CoV-2 based on melting analysis.

Authors:  Ngoc Anh Thi Nguyen; Hoai Thi Bui; Quynh Thi-Huong Pham; Ly Thi Thao Hoang; Hung Xuan Ta; Timo Heikkinen; Duyet Van Le; Trang Dinh Van; Nam Quoc Ngo; Phuong Thi Hong Huynh; Trang Thi Huyen Tran; Hoan Quoc Phan; Luong Van Hoang; H Rogier van Doorn; Diep Thi Ngoc Nguyen; Tam Thi Nguyen; Nam Sy Vo; Cuong Viet Vo; Sau Khac Trinh; Tai The Pham; Quang Duc Le; Phan Van Le; Son Thai Nguyen; Loan Thi Tran; Toan Dinh Vu; Quynh Anh Vu Nguyen; Nguyet Thi Trieu; Thuy Thi Le; Ung Dinh Nguyen; Jakob Steman; Tho Huu Ho
Journal:  Clin Chim Acta       Date:  2022-04-29       Impact factor: 6.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.